Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
126.1 USD | -2.61% | -3.58% | +15.65% |
02:30pm | Merck: positive results for Keytruda in breast cancer | CF |
01:48pm | Merck Says Phase 3 Trial of Keytruda in Triple Negative Breast Cancer Met Overall Survival Endpoint | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.65% | 33TCr | |
+38.30% | 73TCr | |
-7.42% | 35TCr | |
+0.03% | 28TCr | |
+13.47% | 24TCr | |
+7.35% | 21TCr | |
-6.42% | 20TCr | |
+4.14% | 16TCr | |
-1.70% | 16TCr | |
-1.31% | 12TCr |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co. Rises After Berenberg Upgrade